Biotechnology Stocks
| # | 이전 7일 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4555 |  AEON AEON Biopharma, Inc. Class A Common Stock | 0.31 USD | 0.00% | +3.33% | +3.33% | -70.19% | 15.46 M USD | ||
| 4559 |  ICU SeaStar Medical Holding Corporation - Common Stock | 3.49 USD | -6.18% | -7.67% | +12.94% | +41.87% | 15.38 M USD | ||
| 4568 |  NCEL NewcelX Ltd. - Ordinary Shares | 3.11 USD | +2.30% | +9.89% | -5.47% | -38.78% | 14.92 M USD | ||
| 4571 |  KTTA Pasithea Therapeutics Corp. - Common Stock | 0.44 USD | 0.00% | -6.38% | -22.81% | -43.59% | 14.70 M USD | ||
| 4573 |  TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 USD | -17.86% | -30.30% | -28.13% | -89.55% | 14.61 M USD | ||
| 4576 |  TVRD Tvardi Therapeutics, Inc. - Common Stock | 1.08 USD | -1.82% | -13.60% | -40.98% | -70.00% | 14.41 M USD | ||
| 4577 |  KZIA Kazia Therapeutics Limited - American Depositary Shares | 8.82 USD | -5.06% | -8.03% | -24.94% | +50.77% | 14.28 M USD | ||
| 4579 |  HIND Vyome Holdings, Inc. - Common Stock | 2.03 USD | -0.49% | +10.33% | -3.33% | -63.81% | 14.25 M USD | ||
| 4588 |  KPTI Karyopharm Therapeutics Inc. - Common Stock | 0.60 USD | -7.69% | -30.23% | -64.29% | -93.78% | 13.61 M USD | ||
| 4589 |  INAB IN8bio, Inc. - Common Stock | 1.38 USD | -1.43% | -2.82% | +27.78% | -17.37% | 13.60 M USD | ||
| 4590 |  RADX Radiopharm Theranostics Limited American Depositary Shares | 1.15 USD | -2.54% | -20.14% | -45.50% | -84.38% | 13.59 M USD | ||
| 4592 |  CTXR Citius Pharmaceuticals, Inc. - Common Stock | 0.49 USD | -2.00% | -9.26% | -18.33% | -62.60% | 13.45 M USD | ||
| 4596 |  CLRB Cellectar Biosciences, Inc. - Common Stock | 1.40 USD | -7.28% | -28.21% | -40.43% | -55.41% | 13.23 M USD | ||
| 4620 |  PLUR Pluri Inc. - Common Stock | 1.00 USD | -3.85% | -3.85% | -25.37% | -73.82% | 12.34 M USD | ||
| 4626 |  INTS Intensity Therapeutics, Inc. - Common Stock | 3.68 USD | -3.16% | +12.54% | -8.91% | +894.59% | 12.01 M USD | ||
| 4627 |  PASG Passage Bio, Inc. - Common Stock | 3.73 USD | -3.37% | -12.85% | -25.25% | -57.81% | 12.00 M USD | ||
| 4631 |  DARE Dare Bioscience, Inc. - Common Stock | 0.77 USD | -2.53% | -11.49% | +10.00% | -53.33% | 11.77 M USD | ||
| 4635 |  ASBP Aspire Biopharma Holdings, Inc. - Common Stock | 8.30 USD | -3.82% | -0.84% | +1.10% | +432.05% | 11.64 M USD | ||
| 4641 |  PHIO Phio Pharmaceuticals Corp. - Common Stock | 0.99 USD | -1.00% | -1.98% | -3.88% | -16.81% | 11.50 M USD | ||
| 4645 |  TPST Tempest Therapeutics, Inc. - Common Stock | 0.77 USD | -2.53% | -6.10% | -18.09% | -67.78% | 11.40 M USD |
뉴스 Biotechnology Stocks
RBC 캐피털, 리듬 파마슈티컬스에 대한 ‘시장수익률 상회’ 의견 유지···목표주가 159달러로 상향
RBC 캐피털, 엑셀리시스 투자의견 ‘시장수익률’ 유지·목표주가 45달러로 하향
ADC 테라퓨틱스, 주당 1.42달러에 1,290만 주 및 주당 1.32달러에 4,810만 주 매입 워런트 제공하는 8,660만 달러 규모 파이프 파이낸싱 발표; 대출 및 로열티 수정 확보
뉴트리밴드, AVERSA 남용 억제 경피 기술 보호 강화 위해 미국 특허 출원
바이오라인RX, GLIX1 관련 초록 2편이 11월 12~15일 신경종양학회 연례회의에서 발표될 예정이라고 발표
아트리움 테라퓨틱스, 5,170,384주 및 사전 자금 조달 워런트 최대 1,134,930주 매입을 위한 약 7.93달러/주당 5천만 달러 규모의 사모 발표
러시아, 시베리아에서 두 번째 발병 사례 보도 부인 - 블룸버그
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |